Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02269787 · ClinicalTrials.gov registry record · NA

TeleMonitoring to Improve Substance Use Disorder Treatment After Detoxification

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
298
Enrollment target

NCT02269787: Completed NA study, sponsored by VA Office of Research and Development.

NCT02269787 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 298 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02269787, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
298 participants
Enrollment target

Study Summary

This research program is intended to improve the treatment engagement and outcomes of Veterans who receive inpatient detoxification, and decrease their use of VA inpatient and emergency department services. It is intended to increase the use of substance use disorder care and 12-step mutual-help groups to benefit recovery, reduce rehospitalizations, and reduce costs for VA.

Primary Outcome

Percent that had (yes) an additional inpatient detoxification 6 months following baseline assessment- additional inpatient detoxification was dichotomous, yes or no.

Interventions

  • BEHAVIORAL Enhanced Telephone Monitoring

Trial Details

FieldValue
Enrollment Target 298 participants
Start Date 2014-10-01
Est. Completion 2018-03-30
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT02269787 record still lists

NCT02269787 is an interventional study that assigns participants to a tested intervention. The registered 298 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 1 intervention - of which Enhanced Telephone Monitoring is the first listed.

NCT02269787 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02269787 about?

NCT02269787 is a clinical study titled "TeleMonitoring to Improve Substance Use Disorder Treatment After Detoxification". This research program is intended to improve the treatment engagement and outcomes of Veterans who receive inpatient detoxification, and decrease their use of VA inpatient and emergency department services. It is intended to increase the use of substance use disorder care and 12-step mutual-help gro...

What is the current status of trial NCT02269787?

This trial is currently completed. It is a NA study. The enrollment target is 298 participants. The study started on 2014-10-01. Estimated completion is 2018-03-30.

What interventions are being tested in trial NCT02269787?

The interventions under investigation include: Enhanced Telephone Monitoring (BEHAVIORAL).

Who is sponsoring clinical trial NCT02269787?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02269787's enrollment target sits among peer trials

298 371st of 2000 higher than 1,629 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06305624 · 298 participants · NA

    Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease

  • NCT06754215 · 298 participants · NA

    Smoking Cessation Intervention Development for Homeless Youth

  • NCT06780111 · 298 participants · Phase 1

    Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

  • NCT07209358 · 298 participants · NA

    EDX110 Randomized Control Trial for Treatment of DFUs

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02269787, the US trial registry maintained by the National Library of Medicine. NCT02269787 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.